Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding

Part of paid clinical trials in Scranton, Pennsylvania.

Sponsor
Xingshun Qi
Study ID
NCT04662918
Status
Recruiting
Apply to this trial

Conditions

  • GastroIntestinal Bleeding

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Acute gastrointestinal bleeding is potentially lethal in liver cirrhosis. Accurate assessment of prognosis is critical in a timely fashion. A novel model, CAGIB score, has been developed based on our Chinese multicenter retrospective study. Now, a prospective, international multicenter, observational study will be performed to further compare the performance of CAGIB versus Child-Pugh and MELD scores for evaluating the in-hospital mortality of patients with liver cirrhosis and acute gastrointestinal bleeding.

Key Dates

Start date
Jan 1, 2022
Status verified
Oct 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

Mortality [ Time Frame: An average of 1-6 weeks, from admission to discharge ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The Wright Center for Graduate Medical Education, 501 S. Washington AvenueScrantonPennsylvania18503
Hemant Goyal, Dr.
[email protected]

Find similar trials in Scranton, PA

By research site
The Wright Center for Graduate Medical Education, 501 S. Washington Avenue· Scranton, PA

Related Studies